Literature DB >> 4019270

The role of paraaortic node irradiation in the treatment of cancer of the cervix.

D Nori, E Valentine, B S Hilaris.   

Abstract

One hundred and twenty-seven patients with previously untreated carcinoma of the uterine cervix underwent pretreatment laparotomy between 1971 and 1980. Thirty-one were found to have paraaortic metastasis. Twenty-seven patients received paraaortic node external supervoltage radiation to the entire paraaortic chain, 4400 cGy, over 4 1/2 weeks, with 600-800 cGy, boost over 1 week, limited to the area of metastasis as marked at laparotomy. Twenty-nine percent (8/27) of the patients with paraaortic node metastases who were irradiated have survived 5 years or more. These patients have FIGO stages IB, IIA, or IIB; all have epidermoid carcinoma. Three of five patients (60%) with microscopic metastasis and five of twenty-two patients (23%) with gross metastasis in the paraaortic lymph nodes are long-term survivors. None of our long-term survivors have suffered late complications. There have been no fatalities from treatment related complications. We present a radiation technique for paraaortic radiation in these patients, and discuss the indications for paraaortic node radiation in cancer of the cervix.

Entities:  

Mesh:

Year:  1985        PMID: 4019270     DOI: 10.1016/0360-3016(85)90334-7

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Treatment outcomes and prognostic factors in uterine cervical cancer patients treated with postoperative extended field radiation therapy.

Authors:  Hak Jae Kim; Sung Whan Ha; Hong-Gyun Wu
Journal:  J Gynecol Oncol       Date:  2009-12-28       Impact factor: 4.401

2.  [Standard versus individually planned irradiation field in radiotherapy of infradiaphragmatic lymph node sites].

Authors:  M Nevinny-Stickel; S Ennemoser; I Bangerl; D zur Nedden; P Lukas
Journal:  Strahlenther Onkol       Date:  1998-07       Impact factor: 3.621

3.  Definitive extended field intensity-modulated radiotherapy and concurrent cisplatin chemosensitization in the treatment of IB2-IIIB cervical cancer.

Authors:  Guangyu Zhang; Fangfang He; Chunli Fu; Youzhong Zhang; Qiuan Yang; Jianbo Wang; Yufeng Cheng
Journal:  J Gynecol Oncol       Date:  2014-01-08       Impact factor: 4.401

4.  Intensity modulated radiotherapy in carcinoma cervix with metastatic para-aortic nodes: an institutional experience from a Regional Cancer Centre of Eastern India.

Authors:  Misra Biplab; Maji Tapas; Lahiri Debarshi; Roy Sanjoy; Chaudhuri Prabir; Ray K Dilip
Journal:  Rep Pract Oncol Radiother       Date:  2021-06-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.